KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney transplant patients: belatacept trial targets hidden rejection
Disease control Not yet recruitingThis study tests whether switching to belatacept (a drug) plus standard care can better treat early antibody-mediated rejection in kidney transplant patients compared to continuing standard care alone. About 290 adults with new donor-specific antibodies but no kidney function dec…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Stem cell therapy fails to improve kidney rejection, raises safety flags
Disease control Not yet recruitingThis study tested whether a person's own stem cells (mesenchymal stem cells) could help treat chronic active antibody-mediated rejection in kidney transplant recipients. Only 3 patients were enrolled before the study was stopped early due to serious side effects. The treatment di…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
AI takes on kidney transplant rejection in new pilot trial
Disease control Not yet recruitingThis pilot study tests whether an AI-based system can help doctors choose the right doses of immunosuppressant drugs for kidney transplant patients. The goal is to protect the new kidney from damage and rejection. The study will enroll 34 adults who have received a deceased donor…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a lupus drug unlock kidney transplants for Hard-to-Match patients?
Knowledge-focused Not yet recruitingThis study tests whether a short course of belimumab, a drug used for lupus, can improve detection of immune cells that cause transplant rejection. The goal is to help highly sensitized kidney transplant candidates—people whose immune systems are very picky about donor organs—get…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Blood test may replace biopsies for kidney transplant patients
Knowledge-focused Not yet recruitingThis study follows 600 kidney transplant patients to see if a blood test (TruGraf and TRAC) can help doctors manage immunosuppression and detect early signs of rejection. The goal is to improve long-term outcomes by reducing the need for invasive biopsies. Participants will be mo…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Transplant Genomics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC